VALIANT® Captivia VAMC4444C200TURecalls & reported problems
Medtronic, Inc. · STENT GRAFT VAMC4444C200TU VALCAP CLOSE · Class 3 · Implant
All models of VALIANT Captivia (95)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 1
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00643169346444), received between Sep 5, 2022 and Sep 5, 2022 — classified as 1 death.
The most frequently reported specific device problem is “Fracture” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Fracture1
- Leak/Splash1
- Positioning Problem1
Patient problems
- Bradycardia1
- Cardiac Arrest1
- Hypovolemia1
- Pain1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
DeathSep 5, 2022Fracture; Leak/Splash; Positioning Problem; Fracture; Leak/Splash; Positioning Problem
VALIANT CAPTIVIA STENT GRAFTS WERE IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A 70MM THORACIC ANEURYSM. AN OPEN ARCH REPAIR WAS ALSO PREFORMED. APPROXIMATELY 4 YEARS LATER 3 NAVION STENT GRAFTS WERE IMPLANTED. A SEVERE ANGULATED NECK WAS NOTED. IT WAS REPORTED APPROXIMATELY 6 YEARS POST THE INDEX PROCEDURE, AN INTERVENTION PROCEDURE WAS PERFORMED TO RELINE A PREVIOUS VALIANT STENT GRAFT (IMPLANTED IN 2016) DUE TO A FRACTURED GRAFT WITH A TYPE IIIB ENDOLEAK AND SAC INCREASE (100MM). IT WAS NOTED THE PATIENT ALSO PRESENTED WITH PAIN PRE THE INTERVENTION PROCEDURE. DURING THE INTERVENTION THE PHYSICIAN WAS UNABLE TO ADVANCE THE GRAFT (VAMC4444C200TU) THROUGH THE FRACTURED GRAFT FROM THE FEMORAL APPROACH. THE PHYSICIAN USED THE APEX APPROACH HOWEVER DUE TO THE ANGULATED ARCH THE GRAFT COULD NOT BE ADVANCED. THE PATIENT BECAME HEMODYNAMICALLY UNSTABLE WITH BRADYCARDIA AND HYPOVOLEMIA AND WENT INTO CARDIAC ARREST. RESUSCITATION WAS UNSUCCESSFUL AND THE PATIENT EXPIRED. PER THE PHYSICIAN THE CAUSE OF THE FRACTURE, TYPE IIIB ENDOLEAK AND DEATH ARE UNDETERMINED.
Patient problems: Bradycardia; Cardiac Arrest; Hypovolemia; Pain
MAUDE report 15354683 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page